Jean-Luc Herbeaux to become Hovione CEO
Hovione today announced the appointment of Dr. Jean-Luc Herbeaux as Hovione’s Chief Executive Officer, effective 1st April 2022
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Hovione today announced the appointment of Dr. Jean-Luc Herbeaux as Hovione’s Chief Executive Officer, effective 1st April 2022
Hovione, the specialist integrated CDMO, just announced an expansion of its nasal drug delivery capabilities with the addition of a family of innovative nasal powder delivery devices developed in partnership with IDC.
Hovione has once again solidified its position as a top employer.
Safety First, Quality Always: We are continuously improving the safety of our operations with the patient’s safety in mind.
Commitment to partnership and joint innovation for cell and gene therapies
Outsourced Pharma, April 2023